BMJ, doi: 10.1136/bmj.39213.565972.AE, (Published 11 June 2007)

Research

Effects of treatments for symptoms of painful diabetic neuropathy: systematic review

Man-chun Wong, pain management nurse1, Joanne W Y Chung, professor2, Thomas K S Wong, chair professor2

1 Nursing Services Division, United Christian Hospital, 130 Hip Wo Street, Hong Kong, 2 School of Nursing, Hong Kong Polytechnic University, Hong Kong

Correspondence to: M C Wong  wongmc0829{at}yahoo.com.hk

Objective To evaluate the effects of treatments for the symptoms of painful diabetic neuropathy.

Design Systematic review.

Data sources Articles (English and full text) on double blind randomised trials found by searching with the key words anticonvulsant, antidepressant, non-steroidal anti-inflammatory drugs, tramadol, opioid, ion channel blocker, diabetic neuropathy, diabetic peripheral neuropathy, peripheral neuropathy, and neuropathy. The search included Medline, Embase, EMB reviews-AP Journal club, and the Cochrane central register of controlled trials.

Study selection Randomised controlled trials comparing topically applied and orally administered drugs with a placebo in adults with painful diabetic neuropathy.

Data extraction Data were extracted to examine quality of methods, characteristics of studies and patients, efficacy, and side effects. The primary outcome was dichotomous information for 50% or moderate reduction of pain. Secondary outcomes were 30% reduction of pain and withdrawals related to adverse events.

Results Odds ratios were calculated for achievement of 30%, 50%, or moderate pain relief and for withdrawals related to adverse effects. Twenty five reports were included and seven were excluded. The 25 included reports compared anticonvulsants (n=1270), antidepressants (94), opioids (329), ion channel blockers (173), N-methyl-D-aspartate antagonist (14), duloxetine (805), capsaicin (277), and isosorbide dinitrate spray (22) with placebo. The odds ratios in terms of 50% pain relief were 5.33 (95% confidence interval 1.77 to 16.02) for traditional anticonvulsants, 3.25 (2.27 to 4.66) for newer generation anticonvulsants, and 22.24 (5.83 to 84.75) for tricylic antidepressants. The odds ratios in terms of withdrawals related to adverse events were 1.51 (0.33 to 6.96) for traditional anticonvulsants, 2.98 (1.75 to 5.07) for newer generation anticonvulsants, and 2.32 (0.59 to 9.69) for tricylic antidepressants. Insufficient dichotomous data were available to calculate the odds ratios for ion channel blockers.

Conclusion Anticonvulsants and antidepressants are still the most commonly used options to manage diabetic neuropathy. Oral tricyclic antidepressants and traditional anticonvulsants are better for short term pain relief than newer generation anticonvulsants. Evidence of the long term effects of oral antidepressants and anticonvulsants is still lacking. Further studies are needed on opioids, N-methyl-D-aspartate antagonists, and ion channel blockers.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Do adverts subvert? Are bacteria good for us?
Douglas Kamerow
BMJ 2007 335: 0. [Extract] [Full Text]

Treating painful diabetic polyneuropathy
Edward B Jude and Nicolaas Schaper
BMJ 2007 335: 57-58. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Rutkove, S. B. (2009). A 52-Year-Old Woman With Disabling Peripheral Neuropathy: Review of Diabetic Polyneuropathy. JAMA 302: 1451-1458 [Abstract] [Full text]  
  • Alegria, M., Chatterji, P., Wells, K., Cao, Z., Chen, C.-n., Takeuchi, D., Jackson, J., Meng, X.-L. (2008). Disparity in Depression Treatment Among Racial and Ethnic Minority Populations in the United States. Psychiatr. Serv. 59: 1264-1272 [Abstract] [Full text]  
  • Shibata, T., Naruse, K., Kamiya, H., Kozakae, M., Kondo, M., Yasuda, Y., Nakamura, N., Ota, K., Tosaki, T., Matsuki, T., Nakashima, E., Hamada, Y., Oiso, Y., Nakamura, J. (2008). Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats. Diabetes 57: 3099-3107 [Abstract] [Full text]  
  • HORNICK, T., ARON, D. C. (2008). Preventing and managing diabetic complications in elderly patients. Cleveland Clinic Journal of Medicine 75: 153-158 [Abstract] [Full text]  
  • (2007). CARPHOLOGY by Rajendra. PN 7: 350-350 [Full text]  
  • (2007). What's the Best Treatment for Painful Diabetic Neuropathy?. JWatch General 2007: 6-6 [Full text]  
  • Jude, E. B, Schaper, N. (2007). Treating painful diabetic polyneuropathy. BMJ 335: 57-58 [Full text]  

Rapid Responses:

Read all Rapid Responses

Older drugs are still the main choices
Rizaldy Pinzon
bmj.com, 20 Jun 2007 [Full text]
Effects of treatments for symptoms of painful diabetic neuropathy: systematic review
Fenella Lemonsky
bmj.com, 13 Jul 2007 [Full text]
Systematic review on treatments for painful diabetic neuropathy skips important studies and accepts dubious findings in others leading to an invalid treatment algorithm
Søren H Sindrup, et al.
bmj.com, 22 Aug 2007 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ